11 results on '"Hiranmoy Das"'
Search Results
2. Interactive effect of tillage and crop residue management on weed dynamics, root characteristics, crop productivity, profitability and nutrient uptake in chickpea (Cicer arietinum L.) under Vertisol of Central India.
- Author
-
Kaushlendra Pratap Singh, Vasudev Meena, J Somasundaram, Suchi Singh, Mohan Lal Dotaniya, Hiranmoy Das, Ompal Singh, and Ajay Srivastava
- Subjects
Medicine ,Science - Abstract
Tillage and crop residue management play an imperative role in soil physico-chemical properties that eventually affects crop productivity. The objective of the study to find out a compatible combination of tillage and crop residue management for achieving sustainable food production by improving soil properties, providing favorable environment to crop plants. Secondly, managing crop residues effectively to reduce environmental pollution arising due to crop residue burning. With this aim, a field experiment was conducted on six years continued running experiment under conservation agricultural practices during rabi season of 2019-20 on chickpea. The experiment was comprised of five tillage operations with or without crop residue in main plot and three levels of nutrients in sub plots laid out in split plot design with three replications. Reduced Tillage with 60cm residue height (RT60) was recorded higher growth and yield attributes over conventional tillage practice that attributed to economic yield enhancement. The percent yield increment under NT and RT with 30 and 60cm height residue retention varied from 6.91% to 9.67% over conventional tillage. Maximum grain (2380 kg ha-1) and biological output (5762 kg ha-1) was recorded under RT60 (T4), which ascribed to higher net return (Rs 60551 ha-1) and benefit-cost ratio (2.97). The augmentation in net monetary benefit among tillage systems was lies between 24.32% to 37.78% over conventional tillage. The seed protein content ranged between 20.38 to 21.69% among the treatments. Moreover, total N uptake was maximum under RT60, while total P and K uptake was higher in No Tillage with 30cm residue height (T1). No-Tillage with 60cm residue height (NT60) recorded relatively higher soil moisture content (SMC) (22.71 and 15.40%). Treatment NT30 accrued relatively higher value of soil bulk density (1.42 Mg m-3) followed by NT60 and RT60 in comparison to conventional tillage (1.34 Mg m-3). In conclusion, NT and RT with 60cm residue height along with STCR (N3) nutrient dose was found effective for sustainable food production.
- Published
- 2022
- Full Text
- View/download PDF
3. Correction: Impact of Diffusion Barriers to Small Cytotoxic Molecules on the Efficacy of Immunotherapy in Breast Cancer.
- Author
-
Hiranmoy Das, Zhihui Wang, M. Khalid Khan Niazi, Reeva Aggarwal, Jingwei Lu, Suman Kanji, Manjusri Das, Matthew Joseph, Metin Gurcan, and Vittorio Cristini
- Subjects
Medicine ,Science - Published
- 2013
- Full Text
- View/download PDF
4. Impact of diffusion barriers to small cytotoxic molecules on the efficacy of immunotherapy in breast cancer.
- Author
-
Hiranmoy Das, Zhihui Wang, M Khalid Khan Niazi, Reeva Aggarwal, Jingwei Lu, Suman Kanji, Manjusri Das, Matthew Joseph, Metin Gurcan, and Vittorio Cristini
- Subjects
Medicine ,Science - Abstract
Molecular-focused cancer therapies, e.g., molecularly targeted therapy and immunotherapy, so far demonstrate only limited efficacy in cancer patients. We hypothesize that underestimating the role of biophysical factors that impact the delivery of drugs or cytotoxic cells to the target sites (for associated preferential cytotoxicity or cell signaling modulation) may be responsible for the poor clinical outcome. Therefore, instead of focusing exclusively on the investigation of molecular mechanisms in cancer cells, convection-diffusion of cytotoxic molecules and migration of cancer-killing cells within tumor tissue should be taken into account to improve therapeutic effectiveness. To test this hypothesis, we have developed a mathematical model of the interstitial diffusion and uptake of small cytotoxic molecules secreted by T-cells, which is capable of predicting breast cancer growth inhibition as measured both in vitro and in vivo. Our analysis shows that diffusion barriers of cytotoxic molecules conspire with γδ T-cell scarcity in tissue to limit the inhibitory effects of γδ T-cells on cancer cells. This may increase the necessary ratios of γδ T-cells to cancer cells within tissue to unrealistic values for having an intended therapeutic effect, and decrease the effectiveness of the immunotherapeutic treatment.
- Published
- 2013
- Full Text
- View/download PDF
5. Human umbilical cord blood-derived CD34+ cells reverse osteoporosis in NOD/SCID mice by altering osteoblastic and osteoclastic activities.
- Author
-
Reeva Aggarwal, Jingwei Lu, Suman Kanji, Matthew Joseph, Manjusri Das, Garrett J Noble, Brooke K McMichael, Sudha Agarwal, Richard T Hart, Zongyang Sun, Beth S Lee, Thomas J Rosol, Rebecca Jackson, Hai-Quan Mao, Vincent J Pompili, and Hiranmoy Das
- Subjects
Medicine ,Science - Abstract
Osteoporosis is a bone disorder associated with loss of bone mineral density and micro architecture. A balance of osteoblasts and osteoclasts activities maintains bone homeostasis. Increased bone loss due to increased osteoclast and decreased osteoblast activities is considered as an underlying cause of osteoporosis.The cures for osteoporosis are limited, consequently the potential of CD34+ cell therapies is currently being considered. We developed a nanofiber-based expansion technology to obtain adequate numbers of CD34(+) cells isolated from human umbilical cord blood, for therapeutic applications. Herein, we show that CD34(+) cells could be differentiated into osteoblastic lineage, in vitro. Systemically delivered CD34(+) cells home to the bone marrow and significantly improve bone deposition, bone mineral density and bone micro-architecture in osteoporotic mice. The elevated levels of osteocalcin, IL-10, GM-CSF, and decreased levels of MCP-1 in serum parallel the improvements in bone micro-architecture. Furthermore, CD34(+) cells improved osteoblast activity and concurrently impaired osteoclast differentiation, maturation and functionality.These findings demonstrate a novel approach utilizing nanofiber-expanded CD34(+) cells as a therapeutic application for the treatment of osteoporosis.
- Published
- 2012
- Full Text
- View/download PDF
6. Human ovarian tumor cells escape γδ T cell recognition partly by down regulating surface expression of MICA and limiting cell cycle related molecules.
- Author
-
Jingwei Lu, Reeva Aggarwal, Suman Kanji, Manjusri Das, Matthew Joseph, Vincent Pompili, and Hiranmoy Das
- Subjects
Medicine ,Science - Abstract
Mechanisms of human Vγ2Vδ2 T cell-mediated tumor immunity have yet to be fully elucidated.At least some tumor cell recognition is mediated by NKG2D-MICA interactions. Herein, by using MTT assay and PI-BrdU co-staining and Western-blot, we show that these Vγ2Vδ2 T cells can limit the proliferation of ovarian tumor cells by down regulation of apoptosis and cell cycle related molecules in tumor cells. Cell-to-cell contact is critical. γδ T cell-resistant, but not susceptible ovarian tumor cells escape γδ T cell-mediated immune recognition by up-regulating pErk1/2, thereby decreasing surface MICA levels. Erk1/2 inhibitor pretreatment or incubation prevents this MICA decrease, while up-regulating key cell cycle related molecules such as CDK2, CDK4 and Cyclin D1, as well as apoptosis related molecules making resistant tumor cells now vulnerable to γδ T cell-mediated lysis.These findings demonstrate novel effects of γδT cells on ovarian tumor cells.
- Published
- 2011
- Full Text
- View/download PDF
7. Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model.
- Author
-
Hiranmoy Das, Jon C George, Matthew Joseph, Manjusri Das, Nasreen Abdulhameed, Anna Blitz, Mahmood Khan, Ramasamy Sakthivel, Hai-Quan Mao, Brian D Hoit, Periannan Kuppusamy, and Vincent J Pompili
- Subjects
Medicine ,Science - Abstract
Therapeutic potential was evaluated in a rat model of myocardial infarction using nanofiber-expanded human cord blood derived hematopoietic stem cells (CD133+/CD34+) genetically modified with VEGF plus PDGF genes (VIP).Myocardial function was monitored every two weeks up to six weeks after therapy. Echocardiography revealed time dependent improvement of left ventricular function evaluated by M-mode, fractional shortening, anterior wall tissue velocity, wall motion score index, strain and strain rate in animals treated with VEGF plus PDGF overexpressed stem cells (VIP) compared to nanofiber expanded cells (Exp), freshly isolated cells (FCB) or media control (Media). Improvement observed was as follows: VIP>Exp> FCB>media. Similar trend was noticed in the exercise capacity of rats on a treadmill. These findings correlated with significantly increased neovascularization in ischemic tissue and markedly reduced infarct area in animals in the VIP group. Stem cells in addition to their usual homing sites such as lung, spleen, bone marrow and liver, also migrated to sites of myocardial ischemia. The improvement of cardiac function correlated with expression of heart tissue connexin 43, a gap junctional protein, and heart tissue angiogenesis related protein molecules like VEGF, pNOS3, NOS2 and GSK3. There was no evidence of upregulation in the molecules of oncogenic potential in genetically modified or other stem cell therapy groups.Regenerative therapy using nanofiber-expanded hematopoietic stem cells with overexpression of VEGF and PDGF has a favorable impact on the improvement of rat myocardial function accompanied by upregulation of tissue connexin 43 and pro-angiogenic molecules after infarction.
- Published
- 2009
- Full Text
- View/download PDF
8. Impact of Diffusion Barriers to Small Cytotoxic Molecules on the Efficacy of Immunotherapy in Breast Cancer
- Author
-
Zhihui Wang, Jingwei Lu, Hiranmoy Das, Vittorio Cristini, Reeva Aggarwal, Suman Kanji, Metin N. Gurcan, Matthew Joseph, M. Khalid Khan Niazi, and Manjusri Das
- Subjects
Mouse ,Colorectal cancer ,medicine.medical_treatment ,Cancer Treatment ,lcsh:Medicine ,Apoptosis ,Cell Communication ,Targeted therapy ,Diffusion ,Mice ,0302 clinical medicine ,Cancer immunotherapy ,Cytotoxic T cell ,lcsh:Science ,0303 health sciences ,Multidisciplinary ,Systems Biology ,Obstetrics and Gynecology ,Receptors, Antigen, T-Cell, gamma-delta ,Animal Models ,3. Good health ,Treatment Outcome ,Oncology ,030220 oncology & carcinogenesis ,Medicine ,Female ,Immunotherapy ,Research Article ,Adult ,Cell Survival ,Immunology ,Breast Neoplasms ,Models, Biological ,Interferon-gamma ,03 medical and health sciences ,Model Organisms ,Breast cancer ,Cell Line, Tumor ,Breast Cancer ,medicine ,Animals ,Humans ,Biology ,Theoretical Biology ,030304 developmental biology ,business.industry ,lcsh:R ,Computational Biology ,Cancer ,medicine.disease ,Cancer cell ,Cancer research ,lcsh:Q ,business - Abstract
Molecular-focused cancer therapies, e.g., molecularly targeted therapy and immunotherapy, so far demonstrate only limited efficacy in cancer patients. We hypothesize that underestimating the role of biophysical factors that impact the delivery of drugs or cytotoxic cells to the target sites (for associated preferential cytotoxicity or cell signaling modulation) may be responsible for the poor clinical outcome. Therefore, instead of focusing exclusively on the investigation of molecular mechanisms in cancer cells, convection-diffusion of cytotoxic molecules and migration of cancer-killing cells within tumor tissue should be taken into account to improve therapeutic effectiveness. To test this hypothesis, we have developed a mathematical model of the interstitial diffusion and uptake of small cytotoxic molecules secreted by T-cells, which is capable of predicting breast cancer growth inhibition as measured both in vitro and in vivo. Our analysis shows that diffusion barriers of cytotoxic molecules conspire with γδ T-cell scarcity in tissue to limit the inhibitory effects of γδ T-cells on cancer cells. This may increase the necessary ratios of γδ T-cells to cancer cells within tissue to unrealistic values for having an intended therapeutic effect, and decrease the effectiveness of the immunotherapeutic treatment.
- Published
- 2013
- Full Text
- View/download PDF
9. Human Umbilical Cord Blood-Derived CD34+ Cells Reverse Osteoporosis in NOD/SCID Mice by Altering Osteoblastic and Osteoclastic Activities
- Author
-
Thomas J. Rosol, Garrett J. Noble, Richard T. Hart, Brooke K. McMichael, Rebecca D. Jackson, Reeva Aggarwal, Suman Kanji, Manjusri Das, Vincent J. Pompili, Matthew Joseph, Hiranmoy Das, Hai-Quan Mao, Jingwei Lu, Beth S. Lee, Sudha Agarwal, and Zongyang Sun
- Subjects
Anatomy and Physiology ,Mouse ,Bone density ,Osteoporosis ,Cell Culture Techniques ,Osteoclasts ,lcsh:Medicine ,Antigens, CD34 ,Mice, SCID ,Bone remodeling ,Mice ,0302 clinical medicine ,Bone Marrow ,Mice, Inbred NOD ,Osteogenesis ,Immune Physiology ,Molecular Cell Biology ,lcsh:Science ,Musculoskeletal System ,Bone mineral ,0303 health sciences ,Multidisciplinary ,Stem Cells ,Cell Differentiation ,Osteoblast ,Animal Models ,Hematology ,Adult Stem Cells ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Medicine ,Cytokines ,Female ,Cord Blood Stem Cell Transplantation ,Cellular Types ,Research Article ,musculoskeletal diseases ,medicine.medical_specialty ,Bone and Mineral Metabolism ,Immunology ,Osteocalcin ,Bone Marrow Cells ,Bone and Bones ,Bone resorption ,03 medical and health sciences ,Model Organisms ,Calcification, Physiologic ,Rheumatology ,Osteoclast ,Internal medicine ,medicine ,Animals ,Humans ,Bone ,Biology ,030304 developmental biology ,Transplantation ,Osteoblasts ,business.industry ,lcsh:R ,Immunologic Subspecialties ,Hematopoietic Stem Cells ,medicine.disease ,Disease Models, Animal ,Endocrinology ,Immune System ,Women's Health ,Clinical Immunology ,lcsh:Q ,Bone marrow ,business ,Developmental Biology - Abstract
Background Osteoporosis is a bone disorder associated with loss of bone mineral density and micro architecture. A balance of osteoblasts and osteoclasts activities maintains bone homeostasis. Increased bone loss due to increased osteoclast and decreased osteoblast activities is considered as an underlying cause of osteoporosis. Methods and Findings The cures for osteoporosis are limited, consequently the potential of CD34+ cell therapies is currently being considered. We developed a nanofiber-based expansion technology to obtain adequate numbers of CD34+ cells isolated from human umbilical cord blood, for therapeutic applications. Herein, we show that CD34+ cells could be differentiated into osteoblastic lineage, in vitro. Systemically delivered CD34+ cells home to the bone marrow and significantly improve bone deposition, bone mineral density and bone micro-architecture in osteoporotic mice. The elevated levels of osteocalcin, IL-10, GM-CSF, and decreased levels of MCP-1 in serum parallel the improvements in bone micro-architecture. Furthermore, CD34+ cells improved osteoblast activity and concurrently impaired osteoclast differentiation, maturation and functionality. Conclusions These findings demonstrate a novel approach utilizing nanofiber-expanded CD34+ cells as a therapeutic application for the treatment of osteoporosis.
- Published
- 2012
- Full Text
- View/download PDF
10. Human Ovarian Tumor Cells Escape γδ T Cell Recognition Partly by Down Regulating Surface Expression of MICA and Limiting Cell Cycle Related Molecules
- Author
-
Manjusri Das, Hiranmoy Das, Matthew Joseph, Jingwei Lu, Vincent J. Pompili, Reeva Aggarwal, and Suman Kanji
- Subjects
T-Lymphocytes ,Tumor Physiology ,animal diseases ,lcsh:Medicine ,Apoptosis ,Cell Communication ,Metastasis ,Ovarian tumor ,0302 clinical medicine ,Basic Cancer Research ,Cyclin D1 ,lcsh:Science ,Cyclin ,Mitogen-Activated Protein Kinase 1 ,Ovarian Neoplasms ,0303 health sciences ,Mitogen-Activated Protein Kinase 3 ,Multidisciplinary ,biology ,T Cells ,Cell Cycle ,Receptors, Antigen, T-Cell, gamma-delta ,Cell cycle ,Up-Regulation ,Cell biology ,Gene Expression Regulation, Neoplastic ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,Medicine ,Female ,Research Article ,Cell signaling ,Immune Cells ,T cell ,Immunology ,Down-Regulation ,Antigen-Presenting Cells ,chemical and pharmacologic phenomena ,Gene Expression Regulation, Enzymologic ,03 medical and health sciences ,medicine ,Humans ,Biology ,030304 developmental biology ,Cell growth ,lcsh:R ,Cyclin-Dependent Kinase 2 ,Histocompatibility Antigens Class I ,T-cell receptor ,Cyclin-dependent kinase 2 ,Cyclin-Dependent Kinase 4 ,biochemical phenomena, metabolism, and nutrition ,biology.protein ,bacteria ,lcsh:Q - Abstract
Background Mechanisms of human Vγ2Vδ2 T cell-mediated tumor immunity have yet to be fully elucidated. Methods and Findings At least some tumor cell recognition is mediated by NKG2D-MICA interactions. Herein, by using MTT assay and PI-BrdU co-staining and Western-blot, we show that these Vγ2Vδ2 T cells can limit the proliferation of ovarian tumor cells by down regulation of apoptosis and cell cycle related molecules in tumor cells. Cell-to-cell contact is critical. γδ T cell-resistant, but not susceptible ovarian tumor cells escape γδ T cell-mediated immune recognition by up-regulating pErk1/2, thereby decreasing surface MICA levels. Erk1/2 inhibitor pretreatment or incubation prevents this MICA decrease, while up-regulating key cell cycle related molecules such as CDK2, CDK4 and Cyclin D1, as well as apoptosis related molecules making resistant tumor cells now vulnerable to γδ T cell-mediated lysis. Conclusion These findings demonstrate novel effects of γδT cells on ovarian tumor cells.
- Published
- 2011
- Full Text
- View/download PDF
11. Stem Cell Therapy with Overexpressed VEGF and PDGF Genes Improves Cardiac Function in a Rat Infarct Model
- Author
-
Jon C. George, Hai-Quan Mao, Anna Blitz, Nasreen Abdulhameed, Mahmood Khan, Hiranmoy Das, Periannan Kuppusamy, Brian D. Hoit, Matthew Joseph, Ramasamy Sakthivel, Manjusri Das, and Vincent J. Pompili
- Subjects
Male ,Vascular Endothelial Growth Factor A ,Pathology ,Angiogenesis ,medicine.medical_treatment ,Myocardial Infarction ,CD34 ,lcsh:Medicine ,Antigens, CD34 ,030204 cardiovascular system & hematology ,Neovascularization ,0302 clinical medicine ,AC133 Antigen ,lcsh:Science ,Platelet-Derived Growth Factor ,0303 health sciences ,Multidisciplinary ,Neovascularization, Pathologic ,Stem-cell therapy ,Developmental Biology/Stem Cells ,3. Good health ,Haematopoiesis ,medicine.anatomical_structure ,Echocardiography ,Cord blood ,medicine.symptom ,Stem cell ,Cardiovascular Disorders/Myocardial Infarction ,Research Article ,medicine.medical_specialty ,Rats, Nude ,03 medical and health sciences ,Antigens, CD ,Internal medicine ,medicine ,Animals ,Glycoproteins ,030304 developmental biology ,business.industry ,Genetics and Genomics/Gene Therapy ,lcsh:R ,Genetic Therapy ,Rats ,Disease Models, Animal ,Endocrinology ,Connexin 43 ,lcsh:Q ,Bone marrow ,Peptides ,business ,Stem Cell Transplantation - Abstract
Background Therapeutic potential was evaluated in a rat model of myocardial infarction using nanofiber-expanded human cord blood derived hematopoietic stem cells (CD133+/CD34+) genetically modified with VEGF plus PDGF genes (VIP). Methods and Findings Myocardial function was monitored every two weeks up to six weeks after therapy. Echocardiography revealed time dependent improvement of left ventricular function evaluated by M-mode, fractional shortening, anterior wall tissue velocity, wall motion score index, strain and strain rate in animals treated with VEGF plus PDGF overexpressed stem cells (VIP) compared to nanofiber expanded cells (Exp), freshly isolated cells (FCB) or media control (Media). Improvement observed was as follows: VIP>Exp> FCB>media. Similar trend was noticed in the exercise capacity of rats on a treadmill. These findings correlated with significantly increased neovascularization in ischemic tissue and markedly reduced infarct area in animals in the VIP group. Stem cells in addition to their usual homing sites such as lung, spleen, bone marrow and liver, also migrated to sites of myocardial ischemia. The improvement of cardiac function correlated with expression of heart tissue connexin 43, a gap junctional protein, and heart tissue angiogenesis related protein molecules like VEGF, pNOS3, NOS2 and GSK3. There was no evidence of upregulation in the molecules of oncogenic potential in genetically modified or other stem cell therapy groups. Conclusion Regenerative therapy using nanofiber-expanded hematopoietic stem cells with overexpression of VEGF and PDGF has a favorable impact on the improvement of rat myocardial function accompanied by upregulation of tissue connexin 43 and pro-angiogenic molecules after infarction.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.